Showing results (261-270 of 292) with videos related to

Sort By:
Pageof 30
Arthritis and Rheumatism|January 7, 1998
A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener's granulomatosisL Guillevin, J F Cordier, F Lhote, et al.
Experimental Physiology|April 18, 2018
Neuroprotection by post-stroke administration of an oral formulation of angiotensin-(1-7) in ischaemic strokeDouglas M Bennion, Chad H Jones, Lauren L Donnangelo, et al.
Lung Cancer (Amsterdam, Netherlands)|February 13, 2007
Lung cancer in systemic lupus erythematosusJ Bin, S Bernatsky, C Gordon, et al.
Plos One|July 4, 2017
Post-stroke angiotensin II type 2 receptor activation provides long-term neuroprotection in aged ratsDouglas M Bennion, Jacob D Isenberg, Allison T Harmel, et al.
Journal of Immunological Methods|September 13, 1996
Development and standardization of solid phase assays for the detection of anti-neutrophil cytoplasmic antibodies (ANCA). A report on the second phase of an international cooperative study on the standardization of ANCA assaysE C Hagen, K Andrassy, E Csernok, et al.
Annals of the Rheumatic Diseases|January 13, 2001
Autoantibody profiles in the sera of European patients with myositisR Brouwer, G J Hengstman, W Vree Egberts, et al.
Arthritis and Rheumatism|March 1, 1996
The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosusD Gladman, E Ginzler, C Goldsmith, et al.
Lupus|February 14, 2009
European consensus statement on the terminology used in the management of lupus glomerulonephritisC Gordon, D Jayne, C Pusey, et al.
Annals of the Rheumatic Diseases|May 17, 2007
EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including TherapeuticsG Bertsias, J P A Ioannidis, J Boletis, et al.
Annals of the Rheumatic Diseases|April 25, 2008
EULAR points to consider for conducting clinical trials in systemic lupus erythematosus: literature based evidence for the selection of endpointsG K Bertsias, J P A Ioannidis, J Boletis, et al.
Pageof 30